AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aylward, R. B.
Right arrow Articles by Heymann, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aylward, R. B.
Right arrow Articles by Heymann, D. L.
Related Collections
Right arrow Global Health
Right arrow Other Infections
May 2005, Vol 95, No. 5 | American Journal of Public Health 773-777
© 2005 American Public Health Association
DOI: 10.2105/AJPH.2004.055897


COMMENTARY

Can We Capitalize on the Virtues of Vaccines? Insights from the Polio Eradication Initiative

R. Bruce Aylward, MD, MPH and David L. Heymann, MD

The authors are with the Polio Eradication Initiative, World Health Organization, Geneva, Switzerland.

Correspondence: Requests for reprints should be sent to R. Bruce Aylward, MD, Coordinator, Polio Eradication Initiative, World Health Organization, 20, Avenue Appia, CH-1211 Geneva 27, Switzerland (e-mail: aylwardb{at}who.int).

Twenty-five years after the eradication of smallpox, the ongoing effort to eradicate poliomyelitis has grown into the largest international health initiative ever undertaken.

By 2004, however, the polio eradication effort was threatened by a challenge regularly faced by public health policymakers everywhere—misperception about the benefits and risks of vaccines. The propagation of false rumors about oral poliovirus vaccine safety led to the reinfection of 13 previously polio-free countries and the largest polio epidemic in Africa in recent years.

With deft management of such challenges by local, national, and international health authorities, poliomyelitis, a disease that threatened children everywhere just 2 generations ago, could soon be relegated to history like smallpox before it.




This article has been cited by other articles:


Home page
Trop DoctHome page
S Lamina and S Hanif
Paralytic poliomyelitis during the pre-, peri- and post-suspension periods of a polio immunization campaign
Trop Doct, July 1, 2008; 38(3): 173 - 175.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Public Health Association